Palavra-chave: STEM CELL TRANSPLANTATION

NHL AHCST KIR/HLA LATINAMERICAN COOPERATIVE ONCOHEMATOLOGY GROUP NON-MYELOABLATIVE GEMOH AAWP EBMT GROUP ALLOGENEIC HAEMATOPOIETIC AUTOLOGUS HAEMATOPOIETIC SERUM IMMUNOGLOBULIN LEVELS INTERLEUKIN-2 MULTIPLE MYELOMA PATIENTS BLOOD AUTOLOGOUS HEMATOPOIETIC ACUTE MYELOID LEUKAEMIA PERIPHERAL BLOOD AUTOLOGOUS HEMATOPOIETIC TNF CARDIORESPIRATORY CHRONIC MYELOID LEUKEMIA RADOMIZED STUDY CHRONIC GRAFT-VERSUS-HOST HODGKIN´S DISEASE LESS INTENSIVE REGIMEN FOLLOWED F359V INTERLEUKIN-6-174CC BRAZILIAN SINGLE ENTER RISK SCORE THALIDOMIDE POLYMORPHISMS CHRONIC MYELOGENOUS LEUKEMIA NON-HODGKIN LYMPHOMA IMATINIB ERA ADVANCED MULTIPLE MYELOMA HEMATOPOIETIC MALIGNANCIES HIGH-DOSE SEQUENTIAL CHEMOTHERAPY CHRONIC MYELOGENOUS LEUKEMIA IN PHASE CHRONIC NON-HODGKIN S LYMPHOMA HEMATOPOIETIC STEM CELLS HODGKIN LYMPHOMA FRENCH SOCIETY OF HAEMATOLOGY IMATINIB DEXAMETHASONE NON-HODGKIN´S LYMPHOMA TNFA IPI NHL MULTIPLE MYELOMA VACOP-B GRAFT-VERSUS-HOST DISEASE CHEMOTHERAPY THALIDOMIDE+DEXAMETHASONE CHRONIC MEYLOID LEUKEMIA ALLOGENEIC PHL (+) PAROXYSMAL NOCTURNAL HEMOGLOBINURIA BCR-ABL LEUKEMIA IN CHRONIC EBMT IL2 HODGKIN S DISEASE RISK HEMATOPOIETIC MALIGNANCIES MYELODYSPLASTIC SYNDROME HSCT SINGLE AUTOLOGOUS AEROBIC CAPACITY MYELOCYTIC LEUKEMIA GVHD CML MULTICENTER STUDY MALIGNANT LYMPHOMA LATIN AMERICAN COOPERATIVE ONCOHEMATOLOGY GROUP HLA-IDENTICAL GRAFT-VERSUS-DISEASE CYTOKINE PHYSIOTHERAPEUTIC PROTOCOL PROGRESSION-FREE SURVIVAL MUSCLE STRENGTH LACOHG AUTOLOGOUS LEPROSY HLA-MATCHED